Zarzio (PI)
Zarzio (PI) is a biosimilar from Pharma Nova GmbH and is listed on the FOPH Specialities List. As the follow-on product of a biologic it is reimbursed by basic health insurance. The public price ranges from CHF 290.20 to CHF 401.80 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Pharma Nova GmbH
- ATC code
- L03AA02
- IT group
- 06.07.30 Andere
- Active substances
- Filgrastimum ADNr
- Preparation type
- Biosimilar
- On the SL since
- 01/07/2024
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 30 Mio E/0.5ml | Fertspr 5 Stk | CHF 249.88 | CHF 290.20 | 01/07/2024 | A | 7680694050012 |
| Inj Lös 48 Mio E/0.5ml | Fertspr 5 Stk | CHF 351.74 | CHF 401.80 | 01/07/2024 | A | 7680694050029 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
ZARZIO ist indiziert für die Mobilisierung von Vorläuferzellen des peripheren Blutes (PBPC) vor einer Leukapherese, um bei Patienten mit myelosuppressiver Behandlung durch eine Transplantation solcher Zellen die hämatologische Wiederherstellung zu beschleunigen.
Schwere kongenitale Neutropenie (Kostman Syndrom), zyklische Neutropenie, chronische idiopathische Neutropenie (Langzeitanwendung zur Erhöhung der neutrophilen Granulozytenzahl Bereich 1000 bis 3000 Granulozyten pro mcl und Reduktion der Infektionen bei Kindern und Erwachsenen mit klinisch signifikanten Infektionen während der vergangenen 12 Monate und dreimalig dokumentierter schwerster Neutropenie (
More preparations in this group
FAQ
Is Zarzio (PI) covered by Swiss health insurance?
Yes, but only under conditions. Zarzio (PI) is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Zarzio (PI) cost in Switzerland?
The public price is the maximum price set by the FOPH and for Zarzio (PI) ranges from CHF 290.20 to CHF 401.80 per pack. The ex-factory price ranges from CHF 249.88 to CHF 351.74. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages